“CRISPR”

Epicrispr Biotechnologies continued to show encouraging findings from testing of its epigenetic editing treatment for the genetic muscle disease facioscapulohumeral muscular dystrophy. Twelve peopl…

Beam Therapeutics, a Cambridge, MA-based company developing CRISPR base editing therapies, has sued two Chinese scientists and two biotech companies where they work for allegedly stealing Beam’s tr…

Two companies that have spent decades trying to develop cell therapies for diabetes are set to merge, with the aim of working together to take on a market also being pursued by Vertex and CRISPR ...